Next Article in Journal / Special Issue
Promiscuity of the Euonymus Carbohydrate-Binding Domain
Previous Article in Journal
Sumoylation and the DNA Damage Response

Comparative Studies of Vertebrate Platelet Glycoprotein 4 (CD36)

Eskitis Institute for Cell and Molecular Therapies, Griffith University, Nathan, QLD 4111, Australia
Biomolecules 2012, 2(3), 389-414;
Received: 2 August 2012 / Revised: 6 September 2012 / Accepted: 18 September 2012 / Published: 24 September 2012
(This article belongs to the Special Issue Challenges in Glycan, Glycoprotein and Proteoglycan Research)
Platelet glycoprotein 4 (CD36) (or fatty acyl translocase [FAT], or scavenger receptor class B, member 3 [SCARB3]) is an essential cell surface and skeletal muscle outer mitochondrial membrane glycoprotein involved in multiple functions in the body. CD36 serves as a ligand receptor of thrombospondin, long chain fatty acids, oxidized low density lipoproteins (LDLs) and malaria-infected erythrocytes. CD36 also influences various diseases, including angiogenesis, thrombosis, atherosclerosis, malaria, diabetes, steatosis, dementia and obesity. Genetic deficiency of this protein results in significant changes in fatty acid and oxidized lipid uptake. Comparative CD36 amino acid sequences and structures and CD36 gene locations were examined using data from several vertebrate genome projects. Vertebrate CD36 sequences shared 53–100% identity as compared with 29–32% sequence identities with other CD36-like superfamily members, SCARB1 and SCARB2. At least eight vertebrate CD36 N-glycosylation sites were conserved which are required for membrane integration. Sequence alignments, key amino acid residues and predicted secondary structures were also studied. Three CD36 domains were identified including cytoplasmic, transmembrane and exoplasmic sequences. Conserved sequences included N- and C-terminal transmembrane glycines; and exoplasmic cysteine disulphide residues; TSP-1 and PE binding sites, Thr92 and His242, respectively; 17 conserved proline and 14 glycine residues, which may participate in forming CD36 ‘short loops’; and basic amino acid residues, and may contribute to fatty acid and thrombospondin binding. Vertebrate CD36 genes usually contained 12 coding exons. The human CD36 gene contained transcription factor binding sites (including PPARG and PPARA) contributing to a high gene expression level (6.6 times average). Phylogenetic analyses examined the relationships and potential evolutionary origins of the vertebrate CD36 gene with vertebrate SCARB1 and SCARB2 genes. These suggested that CD36 originated in an ancestral genome and was subsequently duplicated to form three vertebrate CD36 gene family members, SCARB1, SCARB2 and CD36. View Full-Text
Keywords: vertebrates; amino acid sequence; CD36; evolution; thrombospondin receptor vertebrates; amino acid sequence; CD36; evolution; thrombospondin receptor
Show Figures

Graphical abstract

MDPI and ACS Style

Holmes, R.S. Comparative Studies of Vertebrate Platelet Glycoprotein 4 (CD36). Biomolecules 2012, 2, 389-414.

AMA Style

Holmes RS. Comparative Studies of Vertebrate Platelet Glycoprotein 4 (CD36). Biomolecules. 2012; 2(3):389-414.

Chicago/Turabian Style

Holmes, Roger S. 2012. "Comparative Studies of Vertebrate Platelet Glycoprotein 4 (CD36)" Biomolecules 2, no. 3: 389-414.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop